Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis on KALYDECO® as Background Therapy
Clinical trial NCT03258424 · COMPLETED
Trial details
- NCT number
- NCT03258424
- Sponsor
- Proteostasis Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-28
- Primary completion
- 2018-10-03
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.